Dallas, TX, United States of America

Joyant Pharmaceuticals, Inc.


USPTO Granted Patents = 16

% Expired Patents = 100.0



Forward Citations = 31

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Gunnar J Hanson (13 out of 183 patents)

silverMedal Ming Zhou (11 out of 33 patents)

bronzeMedal Susan Harran (11 out of 16 patents)

4.  Qi Wei (10 out of 20 patents)

5.  Charles G Caldwell (9 out of 35 patents)

6.  Lai Wang (6 out of 7 patents)

7.  Xiaoming Xu (3 out of 9 patents)

8.  David Thomas (3 out of 3 patents)

9.  Nizal Chandrakumar (3 out of 4 patents)

10.  Patrick G Harran (3 out of 13 patents)

11.  Haizhou Sun (2 out of 2 patents)

12.  Brandon L Probst (1 out of 1 patent)

13.  Gunnar James Hanson (0 patent)

14.  Ming Zhou (0 patent)

15.  Qi Wei (0 patent)


16 patents:

Company Overview
Joyant Pharmaceuticals, Inc. is a biotechnology company based in Dallas, TX, focused on developing innovative therapies for various medical conditions. The organization specializes in the research and development of novel pharmaceutical solutions, leveraging advanced technologies to address unmet medical needs. With a commitment to improving patient outcomes, Joyant Pharmaceuticals aims to bring transformative treatments to market, enhancing the quality of life for individuals affected by challenging health issues.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#129 in Dallas, TX

#1,216 in Texas

#19,922 in US

#37,831 in the World

Dallas, TX (US)
Dallas, TX, United States of America
Forward Citations = 31

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Joyant Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/joyant-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…